Document Page: First | Prev | Next | All | Image | This Release | Search

File: 121096_sep96_decls26_0005.txt
Page: 0005
Total Pages: 5

Subject: DATA FACSIMILE TRANSMISSION REQUEST                             

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: FACSIMILE TRANSMISSION RECORD                                                                   

Document Number:          1

Folder Seq  #:        116


                               -COMM.D@ICA-:DNS-                                                                                                                               ... CALL 697-8840-'
                                                                                                           OPERATIONS
                                                                                                           SUPPORT DIRECTORATE

                               ROUI It,P                                         ZYUW P@.'@AV@'328 2192001                  ADMINISTRATIO,', OF THE PYRIDOSTIG@llhl: ON SCHEDULE. FOR EXAMPLE, IF
                               p 0711457 AUG 90                                                                             THE SITUATION IS SUCH THAT TAKlf,'C THE TABLETS WOULD BE HAZARDOUS,
                               FP, CDRFORSCOM F7 MCP-@RSON GA //FCV.D-PM//                                                  SUCH AS WHEN 11" A TOXIC CHEMICAL AEROSOL ENVIRONMENT OR IN A
                               TO AIC 9879                                       AIG 9169                                   CONTAIW4ATEC AREA AT NIGHT @THOU-, LIGHTING, THEN !I WOULD BE VORC
                               INFO DA WASHINGTON D' //SGPS-PSP//                CNGB W@SHII@STOII DC                       APPROPRIATE IC DELAY TAKING TH,@ MEDICATION FOR A FEW HOURS UNTIL
                               CDRUSAMRICD ABERDEEN PROVING GROUND MD /11                                                   THE TABLETS CAN BE TAKEN' 11, A 'LESS HAZARDOUS ENVIRONMENT.                          @AIJD
                                                                                                                            GUIDELINES SHOULD BE 9EVELOPD TO HANDLE THr PARTICULAR SITUATION.
                               UF.'CLAS                                                                                     8@I IT IS THE RESPONSIBILITY.OF THE CORPS OR DIVISION COMMANDER TO
                                                                    DECIDE WHETHER TO BEGIN, CONTINUE, OR DISCONTIIIUE THE NAPP
                               PASS TO ALL FOPS[OE, AC AND R' UTITT SURGEONS                                                MEDICATION BASED ON THE THREAT.                THE INTELLIGENCE OFFICER OR
                               P.SGID!SYS.RRM/FORSCCW. FCMD-PM//                                                            CHEMICAL OFFICER AND THE SURGEON ACT AS ADVISORS IC THE COMMANDER
                               AMPNI'SU@i: PYRIODSTIGMINE PRETREATMENT FOR N-RV: AGENTS                                     IN MAKING HIS DECISION.        AFTEP, THP.,.@. DAYS OF @ LF-ADMINISTRATION OF
                               REFIA/00./FM 6-285128FEB90/1                                                                 THE MEDICATION BY THE SOLDIEP,. COMBAT CONDITIOFIS SHOULD BE
                               AHPN/P,E- A, SUBJ: TRATMENT OF CHEMICAL AGEN- CASUALTIES AND                                 REEVALUATED BY THE COMMANDER AND HIS STAFF FOP, A DETERMINATION OF
                               CONVEFITIO@'4AL MILITARY CHEMICAL J&'JURIES//                                                WHETHER TO CONTINUE THE MEDI@'ATIO'            'OR NOT. HOUEV@R, ORDERS TO
                               RMKS/1. RECENT IT.'OUIRIES TO THE FO.RSC(N. SURGEON HAVE INDICATED A                         CONTINUE O' DISCONTINUE THE PRETREATMENT CAN AND SHOULD BE MADE AT
                               NEED FOR GUIDANCR ON THE ISSUANCE AND USAG@ 0- DYPIDOSTIGMINE                                ANY TIM;, DEPENDING ON THE SITUATION.              IF THE MEDICATION 15 TO BE
                               BRO(ilD@'. WHICH IS INDICATED FOR PPETREATM.EN-. 0- SC,@                    -DIERS OPERATING CONTINUED. SUPPLIES MUST BE ORDEREE, IN TIME 50 THAT A SECOND PACK
DAY,           CONTINUOUS
                               NERV- A-ENT(S). CHAPTER 2, SECTION V, OF FP. E-2E--. (REF A) CONTAINS                        ADMINISTRATION BEYOND 21 DAYS IS NOT           RECOMMENDED UITHOUT A THOROUGH
                               DETA@LE'C INFORMAT10f, ON THE USAG,' OF PYRIDOST@@Mlf,"'.                   WHILE THIS       EVALUATION a- THE SITUATION.
                               V@ESSAGF SUMMARIIIS AND HIGHLIGHTS SOME OF THAI INFORMATION, IT IS                           9. SOLDIEP.3 MUST BE TRAIPIED TO TAK,          THE NAPP TABLETS FAITHFULLY
                               IMPERAilVE THAI UNIT SURGEONS REVIEW IF, 8-28; It, THE COURSE 0,                             AND CORR-ICTL@ WHEN DIRECTED TO DC, SO, TO ENHANCR THEIR
                               DEVELOPING A UNIT SOP ON THE USE Ol- PYRIDOSTIG@D@-- PRETREATMENT.                           SURVIVABILITY IF THEY ARE EXPOSEC TO           A NERVE A.    FJT.   AN' APPROPRIATE
                               2. PYFIDDSTIGXIN: PRETREATMENT 15 AN ADJUNRT I'                             MARK I NERVE     UNIT SOP P.11@- ALSO BE DEVELOPED At,'j ISSUED FOR TH.: DECONTAMINATION
                               AGENT ANTIDOTE KI-I WHICH ENHANCES THE SURVIV@.51--'@ OF NERVE AGENT                         AND R7TrlrllD:l OF IN" NAPP B ISTEF PACK DURING PERSONNEL
                               POISOfir' CASUALTIS. BEN".'ITS DERIVED FROV, T..'--                         OF THIS          DECONTAMINATION AND OVERGARMENT EXCHANGE.
                               PP,@TP,EATM.Efri P-GIPEK ARE REALIZED ONLY IN N-RV- A'Zlrl CASUALTIES                        10. ALL UNITS WILL OBTAII, NAPP                P@LYS THROUGH MEDICAL SUPPLY
                               WHO HAV- BEEN I-'ATED WITH THE MARK I AT TH@ -' IF.- 'o- NERVE AGENT                         CHANNELS.    @, UNITS WILL NORMALL@ MAINTAIN A OUAtriTY OF THE NAPP/5
TH THE BASIS D@ ISSU,' OF 1 PACK P-IF SOLDIER PLUS AN
                               E HOURS PRIOR IC f."Rl; AGENT EXPOSURE.           PYRID."S-iG@INE PLUS TH@                   ADDITIOTJA. @'-EK/S SUPPLY (TO BE              HELD IN THE UNIT AREA), UNLESS
                               MARK : A.,TIBOT@ F-DU.'@S IN" SEVERITY OF NERVE A"zE?,7 POISONING,'                          OTHERWIS; 'z'P.PPROPRIATE.       NAPP!@ POST BE STOPEE F.:,'RIGERATED It@
                               SHORTENS THE DURATION OF TREATMENT, AND INCREASE, THE SURVIVAL              RATE             TEMPERATURES RANGING FROR, 35 - 46 DEGREES F, If. ORDEP, TO RETAIN
                                                                                                                                           'OR THEIP, FULL SF,'L'- LIFE. NAPP/5 WHICH HAVE
                               O' NERVE AGENT CASUALTIES.                                                                   THEIR POTEt@'.@ r                              i
                               3. THE NERVE AGENT PYRIDOSTIGPIN: PRETREA-,P.-t,- TAE-'-T SET (NAPP)                         EXCEEDED TF,-IF. LABELED EXPIRATION DATE OR HAVE REMAINED
                               CONSISTS OF T@EhT@-ONr 30 MD. PYRIDOSTIGMIf,",- EPLW.TD-- TABLETS, WHICH                     UNREFRI@,RATED FOR MORE THAN Sl@. MONTHS SHOULD                   BE USED.            RC
                               ARE PACKAGED IN A. B'ISTER PACK. EACH NAPP P@'@@. CO!,'TAINS ENOUGH                          UNITS WIL. NORMALLY DRAW TH-.IF. liAPP/5 AT TH@                   ZATION STATION,
                               TABLET,', FOR -' DA@ f 1 TAKEN EVERY & HOURS)                               ARE INITIALLY    BUT SHOULD CCDRDINATE WITF, TH'- KO@ STATION IN ADVANCE TO ENSURE
                               ISSUED NAPP WHEN TH'- CHEMICAL PROTECTIVE                                   15 EXPECTEC TO   CORRE'7 QUANTITIES ARE AVAILABLE WHEN NEEDED.
                                                                                                            OG
                                             4EY ARE THEN RESPON'SIB.7 -C-- 'ARRYIN@ TH-- NAPP                              11. ut'll, F.--.DTCAL PERSONFIEL F.'.TS        BE TRAINED IC, P,-C NIZE THE
                               AND SAzEGUARDI@@'@, 17 AGAINST LOSS. THE NAPP ;' "OR'@ALLY SECUR@D if@                       AND SYM.PT@. 0: PYRIDOSTIGMIfi@ OVCP.DOSE, ALLEPGI' P@'-LACTIONS, AND
                               TH, S.R@VE OP. BR'-,'.S POCKET @ TH' CHEMICAL                                                SIDE EFF'.T!. t@D TO GIV-' EH.ERGEh.@ TREATMENT @ NECESSARY.
                               4. TO E MAXIMATL' EFFECTIVE.  PYRIDOSTI',@@,.- B-INIDE TABLET                                DISCONTINUING PYRIDOSTIGMIN-- SFOULE BE ADEQUAT-. IC ALLEVIATE TH-
                               SHOULD B, TAKEN C.R@l : Y EVERY c HOURS Ot. A                               BASIS PRIOP, TO  SIGNS At@L SYM.DTOMS 0: POST ADVERB: REACTIONS.              EM.RGEUPY TREATV,        tJT
                               -XPOSU':     AGENT.     @EXPOSURE,
                               TO A @,-@RV-                                      IN THIS                   MEANS ACTUAL     FOR ACUT@ O.'@'P,005E P.EOUIRES TH-- ANINISTRATJOli C),-          ATROPINE.
                               POISONING OF TH.; 50-@@IER, NOT  OPERATIO!@@      11, : CONTAMINATED                         INITIALL@, T@@'- 2-M@. ATROPINE       AU7n-It,JECTOP. FOUND       I.,' THE MARR, I K17
                               E@.A'IF.DN@rNT. )SC.DT@-PS SHOULD CONTINUE TAKIT,- 7H@ DYRIDOSTIGY.IN:                       ST
                               U.',Tll A' @ 21 TA3; --T@ IN TH@ E' 13TER PACK HAV' P--I, USED BP, UNTIL                     UNCLAS
                               DIRE'LTE@'TO DISCONTINUE TAKING THE MEDICATION    7- IT IS TO BE                             FINAL SECTION D,' 004'
-         D' 7-'SUED.               THIS             MAY BE       AND It@ V@OS-, CSES @IL- BE 5U                       If ADDITIONAL
                                         At; -@IFFECTIV,' BLOOD LEVEL                                      @.-DICATIO%'. I' ATROPINE     R'OUIPED, 2 MC,. 5F.CULL BE                          By MEDIC@L
                               NOT TAKEN EVERY E HOURS, TH: 5-1@."FICIAL EF, --- I- C-                     DYRIDOSTIGVIti@ AS PERSONNEL -V-P@ l@ TO 20 Y.Ir@IJT-' V@ILE P.0t,'ITO@IN. THE PATIENT.
                               PP,@TP,:ATME14T 51,@','@T'@ICANTLY DYlt,'ISHES AFT@@; e.@,zT THAN 8 HOUR!                    MEDICA              SHOULD AD@t!Sr TH-- COMMAND-IF 0- T@@ OCCURPENC@ O'
                               FROM TP,: LAST TA.; @-i .TH,' US' 0; PYRIDDST!eli;-- @'@-S NOT CHAt,'Gl-                     ANY          PPOBLE@ WITF, @'APv 'D'!Ill!STRATIO'
                               THE AD@@1141STRATIO, 0: THE MARY, I.                                                         12. For A-   FORSC@. SURGED"@,!@               E IS MAJ DAVIC ARDAY, MC,
                               A@TPOUGH NO D-ITF.IMENTAL @@@CT' ART EXPW@-@'                               TX, RECOMMENDED  PREVE@,-,IV- F.-DICIK'E OPFIC;P., A@' 70--3316 DP,      COP 40-'-362-331E.//
                               DOSA@, . DEPENDINS O:; THE LEF;GTF, 0- TIME                                 A' WELL AS       BT
                               INDIVIDUAL PHYSIC-OrIr VARIATIONS, CERTAI@,                                 MIGHT EXP-RiEt_@-
                               ADV7P.57 PEACTlOhS. THESE INCLUDE ABDOMINA-                                 NAUSEA,
                               DIARRH.E@., SKIN R,3F.. MUSCLE WEAKNESS, CRAVP@                             -,TCHIN@, OR
                               DIM@1E.@ OF VISIO@@ DU-' TO PUPILLAR" CONSTRI.'-@@n"                        7r ANY OF THE
                               ABOVE @IGIJSISYMDTC-,- OCCUP., TH@ SC',DIEP. SHOU-@ -C:;@A-T UNIT           Fr'VI"AL
    AS SOO@', P.! POSSIBL'
                               Ek-IL", THE ORDEF TC TAKE PYRIDOS-IGMIN,' H.@.'                             GIVEN, I-. SHOULD
                               BE TA'EL@ AS EVEN IF THE HOPP LEVE.                                         THE PROTECTIVE
                               MP.S;@ 6' WDRI,. ,-, LONG AS THE ENVIPONMEN- !I :@';;-P'fINATED OR 15
                               LIY,EL@'TO BE'09,"SC IT 15 D:SIRABLE TO @0',711;::- T@ PP.ETREATPEli".
                               FO@Ek'Er., IF TH; MISSION REOUIRES SOLDIERS Tr                              IN A
                               rO.@'TA.@'ll@ATED EN'IIP@Otl@ENT FO',. EXTENDED PERIOD@ 'P--ECTIVE
                               PROTECTION OR RES7 AND BELIE'- SHE:TERS SHOUL
                                                                                 :.@,OVIDED SO THAT
                               THEY @A:: REMOV; TF.,IP PROTECTIVR PASK AND TA@:- -iH: TABLITS, OF, TH@'LY
                               SHOULD BE RELO.'ATEE TO AN UNCONTAMINATED AP,-'-                            POSSIOL,-.@
                                                                                                           -1 I I
                               A- TIIEI I IIHMIIIII IA" HAVE II "I@                                        II l@

                               A'TIO@: DASG@4)
                                                                                                           (,.,F@
                               INFO SIB RiviEw@lk

                                                                                                           TGP=9021@,/2016Z TAD=93219/'21--2.Z              CDSN=@IAI-ISC
                               ARM) SECTIONA- NISG                                                                                                                         PAG7               OF
               0711               AUG 90
                                                                                 LY@NCLASSIFIED                                                                            cl@ S-=-           MSG

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 5 f:/Week-36/BX003203/FACSIMILE TRANSMISSION RECORD/data facsimile transmission request:12069615355727
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = FACSIMILE TRANSMISSION RECORD
Folder Seq # = 116
Subject = DATA FACSIMILE TRANSMISSION REQUEST
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 06-DEC-1996